JPMorgan Chase & Co’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-29,459
Closed -$1.17M 6642
2024
Q1
$1.17M Sell
29,459
-3,615
-11% -$143K ﹤0.01% 3471
2023
Q4
$630K Buy
33,074
+1,765
+6% +$33.6K ﹤0.01% 3788
2023
Q3
$358K Buy
31,309
+4,960
+19% +$56.8K ﹤0.01% 3898
2023
Q2
$271K Sell
26,349
-21,800
-45% -$224K ﹤0.01% 4108
2023
Q1
$372K Buy
48,149
+33,919
+238% +$262K ﹤0.01% 3983
2022
Q4
$105K Buy
14,230
+3,657
+35% +$27K ﹤0.01% 4482
2022
Q3
$77K Buy
10,573
+904
+9% +$6.58K ﹤0.01% 4569
2022
Q2
$82K Buy
9,669
+722
+8% +$6.12K ﹤0.01% 4713
2022
Q1
$80K Buy
8,947
+1,697
+23% +$15.2K ﹤0.01% 4835
2021
Q4
$101K Buy
7,250
+2,790
+63% +$38.9K ﹤0.01% 4821
2021
Q3
$48K Hold
4,460
﹤0.01% 4971
2021
Q2
$40K Buy
+4,460
New +$40K ﹤0.01% 4999
2021
Q1
Sell
-5,830
Closed -$73K 5428
2020
Q4
$73K Buy
5,830
+5,827
+194,233% +$73K ﹤0.01% 4365
2020
Q3
$0 Hold
3
﹤0.01% 5078
2020
Q2
$0 Buy
+3
New ﹤0.01% 5010
2017
Q4
Sell
-2,600
Closed -$30K 4748
2017
Q3
$30K Buy
2,600
+1,000
+63% +$11.5K ﹤0.01% 3901
2017
Q2
$15K Buy
+1,600
New +$15K ﹤0.01% 3981
2016
Q4
Sell
-484
Closed -$16K 4569
2016
Q3
$16K Buy
484
+410
+554% +$13.6K ﹤0.01% 3789
2016
Q2
$1K Sell
74
-72,275
-100% -$977K ﹤0.01% 4190
2016
Q1
$1.21M Sell
72,349
-1,201
-2% -$20K ﹤0.01% 2604
2015
Q4
$2.28M Sell
73,550
-9,693
-12% -$300K ﹤0.01% 2322
2015
Q3
$4.32M Buy
83,243
+9,595
+13% +$498K ﹤0.01% 2027
2015
Q2
$4.46M Buy
+73,648
New +$4.46M ﹤0.01% 2144